Afrezza Updates: Upcoming TV Ads and Possibly 'The Uber of Diabetes'?
We're closely following the latest developments with Afrezza, the inhaled insulin that's now been on the market for a little over two years, and has been struggling to gain traction since Sanofi dropped its marketing deal with manufacturers MannKi...
Source: Diabetes Mine - Category: Endocrinology Authors: Mike Hoskins Source Type: blogs